1 Min Read
Nov 2 (Reuters) - Otsuka Holdings Co Ltd -
* Otsuka Canada Pharmaceutical Inc-Health Canada approves Otsuka and Lundbeck’s Abilify Maintena as treatment for bipolar I disorder in adults Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.